Ronnie D. Carroll
Nessuna posizione attualmente
Profilo
Ronnie D.
Carroll joined Cambrex Corp.
in September 1997 as Vice President of Technology and has been Vice President and Chief Technology Officer of Pharmaceutical Technologies since January 2002.
Prior to joining Cambrex, Dr. Carroll held various positions with Bristol-Myers Squibb from 1983 to 1997, including Vice President of Chemical Development for Bristol-Myers Squibb Technical Operations.
From 1966 to 1983, Dr. Carroll held various research and development positions with Pfizer, Inc.
Precedenti posizioni note di Ronnie D. Carroll
| Società | Posizione | Fine |
|---|---|---|
| CAMBREX CORPORATION | Direttore Tecnico/Scientifico/R&S | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Cambrex Corp.
 Cambrex Corp. Pharmaceuticals: GenericHealth Technology Cambrex Corp. engages in the provision of products, services, and technologies to accelerate and improve the development and commercialization of new and generic therapeutics. It supplies to innovator and generic pharmaceutical companies. Its products include generic and branded APIs, controlled substances, chiral compounds, high potency APIs, and advanced intermediates. The company was founded by Arthur Mendolia and Cyril C. Baldwin Jr. in 1981 and is headquartered in East Rutherford, NJ. | Health Technology |
- Borsa valori
- Insiders
- Ronnie D. Carroll
